Literature DB >> 17729402

Can Campylobacter jejuni play a role in development of celiac disease? A hypothesis.

Behnam Sabayan, Farzaneh Foroughinia, Mohammad-Hadi Imanieh.   

Abstract

Celiac disease (CD) is an entropathy with malabsortive condition in which an allergic reaction to the cereal grain-protein (gluten) causes small intestine mucosal injury. CD is a multifactorial disorder in which both genetic and environmental factors contribute to the disease development. Mechanisms have been described to explain the pathology of CD. T cells specific for multiple gluten peptides are found in virtually all patients. Generation of such a broad T cell response may be a prerequisite for disease development. CD is associated with multiple extraintestinal presentations, including neurological deficits. Recent studies have shown a significant correlation between anti-ganglioside antibodies and neurological disorders in patients with underlying CD. Gangliosides are glycosphingolipids which are abundant in nervous system and in other tissues including gastrointestinal tract. It is not known what triggers the release of anti-ganglioside antibodies in people with gluten sensitivity. But, the mechanism is likely to involve the intestinal immune system response to ingested gliadin, a component of wheat gluten. Studies showed that mechanisms different from gluten exposure may be implicated in antibody formation, and other environmental factors may also exist. In addition, considering the fact that genetic predisposition dysregulating mucosal immune responses in the presence of certain environmental triggers like gastrointestinal infections may be strong etiological factors for developing chronic intestinal inflammation including CD, the hypothesis raised in our mind that antiganglioside antibody formation in CD may play a role not only in development of neurological complications in celiac patients, but also in development of CD itself. As presence of Campylobacter jejuni in other diseases with antigangliosides antibody formation has been established, we propose the possible role of Campylobacter jejuni in development of CD in association with other genetic and environmental factors by the mechanism that molecular mimicry of gangliosides-like epitopes common to both lipo-polysacharide coats of certain strains of Campylobacter jejuni and gangliosides in cell structure of gastrointestinal mucosa may cause an autoimmune response and consequently lead to atrophy and degeneration of mucosa possibly by apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729402      PMCID: PMC4611202          DOI: 10.3748/wjg.v13.i35.4784

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Neurologic presentation of celiac disease.

Authors:  Khalafalla O Bushara
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 2.  Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Authors:  Frits Koning; Luud Gilissen; Cisca Wijmenga
Journal:  Springer Semin Immunopathol       Date:  2005-08-10

Review 3.  Celiac disease--sandwiched between innate and adaptive immunity.

Authors:  Dariusz Stepniak; Frits Koning
Journal:  Hum Immunol       Date:  2006-03-30       Impact factor: 2.850

Review 4.  Guillain-Barré syndrome.

Authors:  Richard A C Hughes; David R Cornblath
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

5.  Celiac disease with various presentations.

Authors:  Tumay Doganci; Serap Bozkurt
Journal:  Pediatr Int       Date:  2004-12       Impact factor: 1.524

6.  Transglutaminase-independent binding of gliadin to intestinal brush border membrane and GM1 ganglioside.

Authors:  Armin Alaedini; Norman Latov
Journal:  J Neuroimmunol       Date:  2006-08       Impact factor: 3.478

7.  Neurological manifestations of celiac disease.

Authors:  José Ibiapina Siqueira Neto; Ana Carolina Leite Vieira Costa; Francisco George Magalhães; Gisele Sampaio Silva
Journal:  Arq Neuropsiquiatr       Date:  2004-12-15       Impact factor: 1.420

Review 8.  Cancer vaccines: an update with special focus on ganglioside antigens.

Authors:  Roberto J Bitton; Marcel D Guthmann; Mariano R Gabri; Ariel J L Carnero; Daniel F Alonso; Leonardo Fainboim; Daniel E Gomez
Journal:  Oncol Rep       Date:  2002 Mar-Apr       Impact factor: 3.906

9.  Anti-ganglioside antibodies in children with coeliac disease: correlation with gluten-free diet and neurological complications.

Authors:  C Briani; S Ruggero; G Zara; E Toffanin; M Ermani; C Betterle; G Guariso
Journal:  Aliment Pharmacol Ther       Date:  2004-07-15       Impact factor: 8.171

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.